TORNTPHARM4,925.00

Torrent Pharmaceuticals Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMAJBCHEPHARMMANKINDZYDUSLIFEDIVISLABMAXHEALTHDRREDDYCIPLAMcap ₹1.67L Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
2Y
CAGR
Revenue+21.4+14.2
EBITDA+22.5+16.3
Net Income+11.9+13.6
EPS (adj.)+13.2+14.3
Total Assets+195.6+71.5
Total Equity+131.7+60.2
Free Cash Flow+18.8-9.0
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.